Literature DB >> 19228924

Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease.

Kaori Sato1, Kawori Eizumi, Tomohiro Fukaya, Shigeharu Fujita, Yumiko Sato, Hideaki Takagi, Mai Yamamoto, Naohide Yamashita, Atsushi Hijikata, Hiroshi Kitamura, Osamu Ohara, Sho Yamasaki, Takashi Saito, Katsuaki Sato.   

Abstract

Chronic graft-versus-host disease (cGVHD) is a limiting factor in allogeneic hematopoietic stem cell transplantation (alloHSCT) for the treatment of leukemia and other malignancies. Relative to the process that initiates and promotes cGVHD, the regulation is poorly understood. In this study, we examined the role of naturally occurring regulatory dendritic cells (DC(regs)) in murine major histocompatibility complex (MHC)-compatible and multiple minor histocompatibility antigen (miHAg)-incompatible model of cGVHD in alloHSCT. DC(regs) generated from bone marrow in vitro (BM-DC(regs)) exclusively expressed CD200 receptor 3 (CD200R3), which exerted a suppressive function in the Ag-specific CD4(+) T-cell response. CD49(+)CD200R3(+) cells showed similarities in phenotype and function to BM-DC(regs), which formally distinguishes them from other leukocytes, suggesting that they are the natural counterpart of BM-DC(regs). Treatment of the recipient mice after alloHSCT with the recipient-type CD49(+)CD200R3(+) cells as well as BM-DC(regs) protected against cGVHD, and the protection was associated with the generation of Ag-specific anergic CD4(+) T cells as well as CD4(+)CD25(+)Foxp3(+) regulatory T cells (T(regs)) from donor-derived alloreactive CD4(+)CD25(-)Foxp3(-) T cells. In addition, the depletion of CD49(+)CD200R3(+) cells before alloHSCT enhanced the progression of cGVHD. In conclusion, CD49(+)CD200R3(+) cells act as naturally occurring DC(regs) to regulate the pathogenesis of cGVHD in alloHSCT mediated through the control of the transplanted alloreactive CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228924     DOI: 10.1182/blood-2008-10-183145

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

Review 1.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance.

Authors:  Tomohiro Fukaya; Hideaki Takagi; Yumiko Sato; Kaori Sato; Kawori Eizumi; Honami Taya; Tahiro Shin; Lieping Chen; Chen Dong; Miyuki Azuma; Hideo Yagita; Bernard Malissen; Katsuaki Sato
Journal:  Blood       Date:  2010-06-23       Impact factor: 22.113

4.  E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation.

Authors:  Thomas H Dohlman; Antonio Di Zazzo; Masahiro Omoto; Jing Hua; Julia Ding; Pedram Hamrah; Sunil K Chauhan; Reza Dana
Journal:  Transplantation       Date:  2016-04       Impact factor: 4.939

Review 5.  Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells.

Authors:  Takaaki Hattori; Hiroki Takahashi; Reza Dana
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

6.  Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation.

Authors:  Takaaki Hattori; Daniel R Saban; Parisa Emami-Naeini; Sunil K Chauhan; Toshinari Funaki; Hiroki Ueno; Reza Dana
Journal:  J Leukoc Biol       Date:  2012-01-30       Impact factor: 4.962

7.  Targeting myeloid regulatory cells in cancer by chemotherapeutic agents.

Authors:  Hiam Naiditch; Michael R Shurin; Galina V Shurin
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

8.  Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice.

Authors:  Yuki Kagiyama; Jiro Kitaura; Katsuhiro Togami; Tomoyuki Uchida; Daichi Inoue; Toshihiro Matsukawa; Kumi Izawa; Kimihito C Kawabata; Yukiko Komeno; Toshihiko Oki; Fumio Nakahara; Katsuaki Sato; Hiroyuki Aburatani; Toshio Kitamura
Journal:  Int J Hematol       Date:  2012-10-25       Impact factor: 2.490

Review 9.  Midkine and multiple sclerosis.

Authors:  Hideyuki Takeuchi
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 10.  Tolerogenic dendritic cells: all present and correct?

Authors:  A W Thomson
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.